Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice.

Abstract : Angiotensinogen, a member of the serpin family, is involved in the suppression of tumor growth and metastasis. To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice). Bitransgenic mice overexpressing human angiotensinogen (HCC/Hu-AGT-TG) had a significantly longer survival time than the HCC-TG mice and a reduction of both tumor growth and blood flow velocities in the liver. This antitumor effect of angiotensinogen is related to a reduced angiogenesis, impaired expression of endothelial arterial markers (active Notch4, Delta-like 4 ligand, and ephrin B2) with a decrease of arterial vessel density in HCC/Hu-AGT-TG mice liver. Overexpression of human angiotensinogen decreases angiogenesis, and prevents tumor sinusoids from remodeling and arterialization, thus delaying tumor progression in vivo.
Liste complète des métadonnées

https://hal-unilim.archives-ouvertes.fr/hal-00595860
Contributeur : Françoise Merigaud <>
Soumis le : mercredi 25 mai 2011 - 16:52:17
Dernière modification le : mercredi 23 septembre 2020 - 04:33:55

Lien texte intégral

Identifiants

Collections

Citation

François Vincent, P. Bonnin, M. Clemessy, J.O. Contrerès, N. Lamandé, et al.. Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice.. Cancer Research, American Association for Cancer Research, 2009, 69 (7), pp.2853-60. ⟨10.1158/0008-5472.CAN-08-2484⟩. ⟨hal-00595860⟩

Partager

Métriques

Consultations de la notice

118